Eagle Pharmaceuticals, Inc. (EGRX)

United States

opens in 1d 8h 45m

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,054.94 -0.51%
EUR/USD 1.15 0.00%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.65 0.01%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,054.94 -0.51%
EUR/USD 1.15 0.00%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.65 0.01%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,054.94 -0.51%
EUR/USD 1.15 0.00%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.65 0.01%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,054.94 -0.51%
EUR/USD 1.15 0.00%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.65 0.01%
XPT/USD 1,003.20 0.33%

0.25 USD

0.165

194.12%

Last update Nov 7, 9:30 AM EST

Market closed

Day range

0.25

Previous close

0.085000001

Open

0.25

Access this stock data via API

Eagle Pharmaceuticals, Inc.

0.25

0.16

194.12%

Overview

Access /time_series data via our API — starting from the Basic plan and above.

Description

Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, manufacturing, and commercialization of innovative therapies for hospital-administered critical care, oncology, and rare disease treatment. The company specializes in complex injectable formulations and generics, including notable products like Bendeka and Belrapzo for leukemia and lymphoma, as well as Ryanodex for managing malignant hyperthermia. Eagle Pharmaceuticals maintains an active pipeline targeting the central nervous system, metabolic critical care, and cancer, aiming to address unmet medical needs with both novel drugs and reformulated products. Their integrated capabilities span research and development, clinical trials, manufacturing, and commercial distribution. Eagle collaborates with contract development and manufacturing organizations and leverages strategic partnerships for broader regulatory and global market access. By concentrating on underserved therapeutic areas and the hospital market, Eagle Pharmaceuticals plays a key role in advancing specialized treatments that improve patient outcomes within the U.S. healthcare system.

About

CEO

Mr. Michael Graves

Employees

134

Address

50 Tice Boulevard
Suite 315
Woodcliff Lake, 07677, NJ
United States

Phone

201 326 5300

Website

eagleus.com

Instrument type

Common stock

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

MIC code

PINX

Access /profile data via our API — starting from the Grow plan (individual) and the Venture plan (business) and above.

Latest press releases

Dec 24, 2025

HALPER SADEH LLC ENCOURAGES EAGLE PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

NEW YORK, Dec. 24, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Eagle Pharmaceuticals, Inc. (OTCPK: EGRX) breached their fiduciary duties to shareholders.

If you currently own Eagle stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about your legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. Our firm would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Why Your Participation Matters:

Shareholder involvement can help improve a company's policies, practices, and oversight mechanisms to create a more transparent, accountable, and effectively managed organization, which can enhance shareholder value.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

One World Trade Center

85th Floor

New York, NY 10007

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-eagle-pharmaceuticals-inc-shareholders-to-contact-the-firm-to-discuss-their-rights-302649288.html

SOURCE Halper Sadeh LLP

Access /press_releases data via our API — starting from the Basic plan and above.